Previous Article | Next Article 
Infection and Immunity, November 1999, p. 5626-5633, Vol. 67, No. 11
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Endothelial Adhesion Molecule Expression and Its
Inhibition by Recombinant Bactericidal/Permeability-Increasing Protein
Are Influenced by the Capsulation and Lipooligosaccharide Structure of
Neisseria meningitidis
Garth L. J.
Dixon,1,*
Robert S.
Heyderman,2
Karolena
Kotovicz,1
Dominic L.
Jack,1
Svein R.
Andersen,3
Ulrich
Vogel,4
Matthias
Frosch,4 and
Nigel
Klein1
Immunobiology Unit, Institute of Child
Health, London,1 Department of Pathology
and Microbiology, School of Medical Sciences,
Bristol,2 and The Edward Jenner
Institute for Vaccine Research Compton,
Newbury,3 United Kingdom, and Institut
für Hygiene und Mikrobiologie, Universität Würzburg,
97080 Würzburg, Germany4
Received 19 May 1999/Returned for modification 1 July 1999/Accepted 12 August 1999
 |
ABSTRACT |
Vascular endothelial injury is responsible for many of the clinical
manifestations of severe meningococcal disease. Binding and migration
of activated host inflammatory cells is a central process in vascular
damage. The expression and function of adhesion molecules regulate
interactions between leukocytes and endothelial cells. Little is known
about how meningococci directly influence these receptors. In this
study we have explored the effect of Neisseria meningitidis
on endothelial adhesion molecule expression and found this organism to
be a potent inducer of the adhesion molecules CD62E, ICAM-1, and
VCAM-1. Exposure of endothelium to a serogroup B strain of
Neisseria meningitidis, B1940, and a range of isogenic
mutants revealed that lipooligosaccharide (LOS) structure and
capsulation influence the expression of adhesion molecules. Following
only a brief exposure (15 min) to the bacteria, there were large
differences in the capacity of the different mutants to induce vascular
cell adhesion molecules, with the unencapsulated and truncated LOS
strains being most potent (P < 0.05). Furthermore, the pattern of cell adhesion molecule expression was different with
purified endotoxin from that with intact bacteria. Meningococci were
more potent stimuli of CD62E expression than was endotoxin, whereas
endotoxin was at least as effective as meningococci in inducing ICAM-1
and VCAM-1. The effect of bactericidal/permeability increasing protein
(rBPI21), an antibacterial molecule with antiendotoxin properties, was also dependent on LOS structure. The strains which possessed a truncated or nonsialylated LOS, whether capsulated or not,
were more sensitive to the inhibitory effects of rBPI21. These findings could have important implications for the use of antiendotoxin therapy in meningococcal disease.
 |
INTRODUCTION |
Infections caused by Neisseria
meningitidis remain an important cause of mortality and morbidity
worldwide (14). It is the organism responsible for the
majority of childhood cases of bacterial meningitis in the United
Kingdom, and in patients presenting with severe shock, mortality may be
as high as 50%. Although prompt recognition, early treatment and
intensive care has reduced this figure in recent years (18),
survivors may have extensive tissue injury, sometimes requiring
amputation and/or skin grafting.
Capillary leak and intravascular thrombosis are serious consequences of
meningococcal sepsis and are indicative of widespread vascular
endothelial injury (23). Histological studies of
meningococcal disease show that cutaneous lesions contain large numbers
of organisms that are associated with the vascular endothelium
(11). Recent studies have also shown that meningococci have
the capacity to bind endothelial cells in a receptor-ligand-specific
fashion (33, 34) and indicate that bacterium-endothelium
contact may itself be critical in mediating the vascular injury seen in
this disease (29). There is evidence that meningococci, both
alone and in the presence of neutrophils, can lead to endothelium
damage (20, 32). However, there is still very little
information on how meningococci may themselves modulate the influx of
neutrophils into inflammatory sites.
Expression of adhesion molecules by the vascular endothelium is a
critical step in the inflammatory response. Leukocyte adhesion occurs
through a complex and multistep process involving initial tethering and
then rolling of leukocytes by low-avidity interactions with mainly the
selectin family of cell adhesion molecules (e.g., CD62E/E-selectin).
This is followed by firmer adhesion, which is mediated largely by
higher-affinity interactions involving the members of the
immunoglobulin Ig superfamily (e.g., ICAM-1 and VCAM-1) on endothelial
cells (30). After firm adhesion, transendothelial and
subendothelial migration may occur, a process also involving leukocyte
integrins and complex cross talk among leukocytes, the endothelium,
cytokines, and chemokines. The initial inflammatory stimulus to this
activation cascade is critical since it determines which leukocytes
will participate in the subsequent inflammatory response
(4). The pattern of endothelial activation seen in response
to the proinflammatory cytokines tumor necrosis factor alpha,
interleukin-1, and CD40 (17) and bacterial endotoxin has
been described (5, 39). There is very limited information on
the response of endothelial adhesion molecules to live meningococci.
We have previously shown that encapsulation and lipooligosaccharide
(LOS) structure influence the host inflammatory response to N. meningitidis (20). In this study, we have used isogenic mutants of N. meningitidis B1940 to investigate the
relationship between bacterial structure and the expression of adhesion
molecules on cultured human endothelial cells. We have also explored
the effect of human recombinant bacterial/permeability increasing protein (rBPI21) (2) to modulate endothelial
activation by these organisms.
 |
MATERIALS AND METHODS |
Bacterial strains.
The parent organism, N. meningitidis B1940, and three isogenic mutants derived from it
have been described previously (7). The capsule-deficient
(siaD), mutant of B1940 was constructed by using insertional
inactivation of the polysialyltransferase gene. Inactivation of the
galE gene by replacement of the cpsD region with
a chloramphenicol resistance marker produces a capsulated mutant that
expresses a truncated LOS that cannot be sialylated. In the
cps mutant, the whole cps gene complex is
missing, and so it has both defective capsule expression and a
truncated LOS. A fourth mutant, the lst mutant of B1940, has
a deleted
-2,3-sialyltransferase gene and cannot sialylate terminal
lacto-N-neotetraose of its LOS (36). The parent
bacterium, B1940, and its derived mutants express pili and both Opa and
Opc as indicated by electron microscopy and immunoreactivity with
specific monoclonal antibodies (20).
Materials.
rBPI21, a recombinant, modified
amino-terminal fragment of bactericidal/permeability increasing factor,
was a kind gift from XOMA (US) LLC, Berkeley, Calif. Escherichia
coli lipopolysaccharide (LPS) (protein content, <1%), serotype
O111:B4, was purchased from Sigma, Poole, United Kingdom. LOS from
N. meningitidis serogroup B (strain 44/76) was prepared as
previously described (1). Briefly, LPS was extracted by hot
aqueous phenol extraction, ultracentrifugation, gel filtration, and
cold-ethanol-NaCl precipitation (31). The final product
contained <0.3% protein and was without detectable nucleic acids.
Bacterial culture.
All the above strains were grown on
gonococcal agar (Difco) supplemented with Vitox (Oxoid) and cultured in
6% CO2 in air at 36°C. In all experiments, the bacteria
used were subcultured at least once and were used after 18 h.
Suspensions of bacteria were prepared in RPMI 1640 medium with no
phenol red (Gibco, Paisley, United Kingdom), and their optical density
was measured at 540 nm. Bacterial viability counts were measured by a
modification of Miles and Misra technique (24). In some
experiments, nonviable bacteria were used. These were killed either
with 0.5% paraformaldehyde or by heating at 56°C for 30 min.
Endothelial-cell culture.
Human umbilical vein endothelial
cells (HUVEC) were obtained by collagenase type 2 (Gibco) digestion as
described previously with some modifications (21). Cells in
primary culture were grown in MCDB 131 medium (Gibco) supplemented with
2 mM L-glutamine, penicillin, streptomycin, and 20%
heat-inactivated fetal calf serum (Gibco) in 25-cm2 tissue
culture flasks (Becton Dickinson, Oxford, United Kingdom). The cells
were then passaged into 24-well plates, previously treated with
endothelial attachment factor, by using trypsin-EDTA (Sigma). The cells
were grown to confluence and then washed thoroughly, 24 to 48 h
prior to experiments, in antibiotic-free RPMI 1640 medium supplemented
with 25 mM HEPES buffer, 2 mM L-glutamine (Gibco), and 20%
heat-inactivated fetal calf serum (Gibco).
Incubation of N. meningitidis with HUVEC.
Initial experiments were conducted with either heat-inactivated or
0.5% paraformaldehyde-fixed bacteria. In subsequent experiments, HUVEC
were stimulated with endotoxin or live meningococci and then incubated
for up to 24 h at 37°C. Each well of confluent HUVEC contained
approximately 105 cells, so that the ratio of bacteria to
HUVEC ranged from 1:0.01 to 1:100. In some experiments, HUVEC were
exposed to bacteria or LPS before being washed in fresh RPMI medium
containing 20% fetal calf serum, and incubated for a further 5 h.
The cells were then removed from culture plates by incubation in
Puck's A saline followed by gentle mechanical scraping. Adhesion
molecule expression was detected by incubation with mouse monoclonal
antibodies to human ICAM-1, CD62E, and VCAM-1 (Serotec, Oxford, United
Kingdom) followed by goat anti-mouse F(ab')2-phycoerythrin
conjugate (Dako, High Wycombe, United Kingdom). Nonspecific binding of
antibodies was controlled for by inclusion of an irrelevant
isotype-matched control (Dako). Samples were washed, resuspended in
Cellfix (Becton Dickinson), and analyzed by flow cytometry
(FACScalibur; Becton Dickinson) with Cell Quest software (Becton
Dickinson). The endothelial-cell population was identified by its
forward-scatter and side-scatter position and by expression of CD31
(Serotec). For each sample, 5,000 events were collected within the
Endothelial gate.
Statistics.
All experiments were done at least three times
on independent primary cell cultures from different sources. Where
statistical analysis is shown, the results are expressed as mean median
fluorescence intensity and standard error of the mean. A comparison of
ranking order of cellular adhesion molecule expression by parent and
cpsD, siaD, and cps mutant strains was
analyzed by a Kruskall-Wallis one-way analysis of variance.
 |
RESULTS |
HUVEC adhesion molecule expression induced by N. meningitidis B1940.
Incubation of endothelial cells with the
parent organism induced the expression of CD62E, VCAM-1, and ICAM-1.
With 106 organisms per ml, CD62E expression was first
detected at 2 h, reached maximal levels at 5 h, and
diminished markedly by 24 h. VCAM-1 expression was not detected
until 4 h, and it reached maximal levels between 12 and 18 h.
Similar levels were still seen at 24 h. ICAM-1 was expressed on
resting HUVEC, but the levels were seen to increase by 4 h and
were still rising by 24 h. Similar levels and kinetics of these
adhesion molecules were seen with 10 ng of E. coli LPS per ml.
Influence of capsulation and LOS structure on endothelial cell
adhesion molecule expression.
To examine the influence of
capsulation and LOS structure on HUVEC adhesion molecule expression,
HUVEC were exposed to the B1940 isogenic mutant organisms. When the
endothelial cells were incubated with bacteria for 5 h, the
magnitude of CD62E, ICAM-1, and VCAM-1 expression induced by the
mutants was similar to that seen with the parent (capsulated,
sialylated LOS) organism. However, when HUVEC were exposed to bacteria
for shorter periods, differences in adhesion molecule expression became
apparent. This was most marked after only 15 min of exposure. Under
these conditions, the siaD (unencapsulated, sialylated LOS)
and cps (unencapsulated, truncated LOS, nonsialylated)
mutants consistently induced higher levels of all three adhesion
molecules than did the parent. This was particularly marked for CD62E
and VCAM-1 (Fig. 1). Expression induced
by the cpsD (capsulated, truncated LOS, nonsialylated) organism was always higher than that induced by the parent but not
usually to the levels observed with the siaD and
cps mutants (Fig. 1). Interestingly, in separate experiments
comparing the parent and the cpsD and lst
(capsulated, nonsialylated LOS) mutants, the level of cell adhesion
molecules seen with the lst organisms was between those seen
with the parent and the cpsD mutant. Similar results were
obtained when live meningococci were replaced with bacteria that were
either heat inactivated or fixed in 0.5% paraformaldehyde (results not
shown).

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 1.
Expression of ICAM-1 (A), E-selectin (B), and VCAM-1 (C)
on HUVEC at 5 h after incubation with the N. meningitidis parent strain and cps, siaD,
and cpsD mutants at 106 organisms per ml. HUVEC
were washed thoroughly in fresh medium after 15 min of incubation with
organisms. E. coli LPS was added at 10 ng per ml, and the
cells were left unwashed. Results here are expressed as means and
standard errors of the mean. #, P = 0.03; *, P = 0.015; +, P = 0.045.
|
|
Once the patterns of adhesion molecule expression under these
conditions had been established, the influence of bacterial concentration was investigated. Figure 2
shows the effect of bacterial concentration on CD62E expression. The
pattern of adhesion molecule expression as shown in Fig. 1 was
preserved at all the concentrations tested. There was a threshold
bacterial concentration at which no adhesion molecule expression was
observed. This differed between the parent and siaD mutant
by at least 1 log unit in bacterial concentration (Fig. 2). Similar
results were seen with ICAM-1 and VCAM-1 (results not shown).

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 2.
Differential induction of CD62E on HUVEC by the N. meningitidis B1940 parent and the cpsD and
siaD mutants occurs over a range of bacterial
concentrations. Bacteria were added at 108 to
104 organisms per ml. After 15 min of incubation, HUVEC
were washed thoroughly in fresh medium and incubated for a further
5 h. CD62E expression was determined at 5 h by flow
cytometry. This is representative of at least three experiments
yielding similar results.
|
|
E. coli LPS and meningococcal LOS cause a different
pattern of adhesion molecule expression to N. meningitidis
B1940 and isogenic mutants.
When HUVEC were incubated with
purified E. coli LPS or meningococcal LOS, the profiles of
CD62E, ICAM-1, and VCAM-1 expression observed by flow cytometry were
similar (Fig. 3). In comparison, N. meningitidis induced greater expression of CD62E than did purified endotoxin from either bacterial species, even when very high endotoxin doses (100 ng/ml) were used. Endotoxin from either source was at least
as effective at up-regulating ICAM-1 or VCAM-1 as were the bacteria
(Fig. 3).

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 3.
Flow cytometric analysis of expression of CD62E, ICAM-1,
and VCAM-1 on HUVEC following 5 h of incubation with 100 ng of
E. coli O111:B4 LPS, 100 ng of meningococcal LOS, and
107 N. meningitidis B1940 parent and
siaD mutant organisms per ml. Shaded areas represent CD62E,
ICAM-1, and VCAM-1 staining in response to stimuli; the solid line
represents cell adhesion molecule staining in unstimulated cells; and
the dotted line represents staining with an irrelevant mouse
immunoglobulin G1 antibody. Numbers on each plot are median fluorescent
intensities and percent positive events for stimulated cells. Data
presented here is representative of three experiments yielding similar
results.
|
|
Results shown in Fig. 1 demonstrated that a short exposure of the HUVEC
to unencapsulated siaD and cps meningococcal
mutants induced higher levels of CD62E expression than did continuous exposure to purified endotoxin, whereas endotoxin induced higher levels
of ICAM-1 and VCAM-1 expression. To investigate this further, HUVEC
were incubated with either E. coli LPS or the N. meningitidis B1940 parent or siaD mutant for increasing
lengths of time, ranging from 1 min to 3 h, before being washed
thoroughly to remove free LPS and/or nonadherent organisms. Cultures
were incubated for a further 5 h, after which time adhesion
molecule expression was measured by flow cytometry. There was minimal
induction of CD62E expression on HUVEC exposed to LPS for less than 15 min (Fig. 4A). For exposures of 15 min or
more, CD62E expression could be detected. Similar results were obtained
with ICAM-1 and VCAM-1 (data not shown). Increasing the duration of
HUVEC exposure to LPS also increased the level of adhesion molecule
expression, so that maximal expression was seen at 5 h. When the
kinetics of adhesion molecule expression were examined by using the
parent organism, the profiles were similar to that seen with LPS (Fig. 4B). The pattern of expression was very different when the experiments were performed with the siaD mutant. CD62E expression was
detected after only a 5-min exposure (Fig. 4B), reached a peak at 60 min, and declined progressively by 5 h. Similar differences were
observed with ICAM-1 and VCAM-1 (results not shown).

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 4.
Brief exposure of the unencapsulated siaD
mutant to HUVEC is a potent inducer of expression of CD62E. (A)
N. meningitidis B1940 siaD mutant at
106 organisms per ml or 10 ng of E. coli LPS was
added to HUVEC, which were then washed thoroughly with fresh medium at
5, 15, 60, 120, and 240 min. (B) N. meningitidis B1940
siaD and parent organisms were incubated at 106
organisms per ml and washed at 15, 60, 120, and 240 min. CD62E
expression was determined by flow cytometry after 5 h of
incubation. The results shown here are representative experiments from
at least three separate experiments that yielded similar results.
|
|
Bacterial concentration, LOS structure, and capsulation influence
the inhibitory effect of rBPI21 on the induction of HUVEC
adhesion molecule expression by meningococci.
The effects of the
endotoxin antagonist rBPI21 on the induction of HUVEC
adhesion molecule expression were investigated. When 10 µg of rBPI
per ml was added prior to or at the same time as 100 ng of E. coli LPS per ml, adhesion molecule expression was completely
inhibited (Fig. 5). However, when
rBPI21 was added to meningococci, the pattern of cell
adhesion molecule expression was more complicated. First, the bacterial
concentration was found to be important. When 10 µg of
rBPI21 per ml was added to either the parent B1940 or
siaD mutant at 104 organisms/ml, there was a
marked reduction in adhesion molecule expression. However, when the
bacterium was present at 105 organisms/ml, inhibition was
only between 20 and 50%. Little effect was observed at 106
organisms/ml (Fig. 6). Second, LOS
structure and encapsulation also influenced the efficacy of
rBPI21. When 105 organisms of N. meningitidis B1940 or the isogenic mutants per ml were incubated
with rBPI21, the levels of CD62E expression were more
efficiently inhibited for the cps and cpsD
mutants than for either the parent or siaD mutant (Fig.
7A). In separate experiments, the level
of inhibition seen with the lst mutant was similar to that
observed with the cps and cpsD mutants (Fig. 7B),
indicating that LOS sialylation may be the major determinant of this
effect. rBPI21-mediated inhibition of either ICAM-1 or
VCAM-1 up-regulation by meningococci was similar to that seen with
CD62E expression (results not shown).

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 5.
Effect of rBPI21 on E. coli
O111:B4 LPS-induced HUVEC expression of CD62E, ICAM-1, and VCAM-1.
E. coli LPS (100 ng/ml) was added to HUVEC preincubated with
10 µg of rBPI21 per ml. Cell adhesion molecule
determination was determined by flow cytometry after 5 h of
incubation. The results shown are representative of multiple
experiments with same level of inhibition.
|
|

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 6.
Effect of rBPI21 on HUVEC expression of
CD62E by various doses of the N. meningitidis B1940
siaD mutant. rBPI21 (10 µg/ml) or medium was
added to HUVEC, and then either 100 ng of E. coli O111:B4
LPS or various concentrations of bacteria were added as shown. CD62E
expression was determined after 5 h. The data presented here are
histograms of fluorescence intensity of phycoerythrin fluorochrome
plotted against the number of events. The dotted line represents
resting CD62E expression; the shaded area represents CD62E expression
with LPS or bacteria; and the continuous black line represents CD62E
expression when LPS or bacteria were preincubated with
rBPI21.
|
|

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 7.
Effect of rBPI21 on induction of CD62E
expression on HUVEC in response to N. meningitidis B1940
parent and cps, siaD, and cpsD mutants
(A) and B1940 parent and the lst mutant (7B). HUVEC were
pre-incubated with 10 µg of rBPI21 per ml, and then
105 organisms/ml were added. CD62E expression was measured
after 5 h by flow cytometry. The results shown are the mean median
fluorescence intensity (MFI) and standard error of the mean from three
separate experiments.
|
|
The influence of rBPI21 on induction of HUVEC adhesion
molecule expression after exposure to N. meningitidis or
endotoxin.
The capacity of rBPI21 to influence
adhesion molecule expression after bacterial exposure was investigated.
HUVEC were exposed to either the parent (nonadherent) or the
siaD mutant (adherent) for 15 min before washing.
rBPI21 was then added at 15, 60, and 120 min after
bacterial exposure. A reduction of between 40 and 60% in the
expression of CD62E was observed when rBPI21 was added after a 15-min exposure to the bacteria (Fig. 8). This
level of inhibition was similar even if rBPI21 was added at
60 or 120 min. While the siaD mutant induced higher levels
of CD62E than the parent organism, the relative effect of
rBPI21 was similar for both organisms.

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 8.
Effect of time exposure of rBPI21 on
induction of CD62E on HUVEC after 5 h of stimulation with 10 ng of
E. coli O111:B4 LPS or N. meningitidis B1940
parent and siaD mutant strains. Bacteria were added at
106 per ml and washed off after 15 min. Then 5 µg of
rBPI21 was added at 15, 60, and 120 min. E. coli
O111:B4 LPS (10 ng) was added, and 5 µg of rBPI21 was
added at the same time points. The results shown are a representative
of three experiments with similar results.
|
|
 |
DISCUSSION |
The nature and degree of the host inflammatory response to
N. meningitidis may determine the fate of an infected
individual. While host factors such as cytokine gene polymorphisms are
likely to be determinants of this response, there is increasing
recognition that bacterial properties are also important. This study
provides evidence that bacterial composition can influence host
endothelial cell responses. In view of the importance of vascular
injury in this condition, these findings may be pertinent to
understanding the pathophysiology of meningococcal disease.
In this study, we have used HUVEC to investigate the expression of
adhesion molecules in response to N. meningitidis. We found this organism to be a potent inducer of the major vascular endothelial cell adhesion molecules, CD62E, ICAM-1, and VCAM-1, even after only
limited periods of exposure. Our previous studies have shown that
meningococci also markedly enhance the expression of the
2-integrin CD11b/CD18 and diminish the expression of the
selectin CD62L on neutrophils (20). Since these
counterreceptors on both cell types are responsible for neutrophil
adhesion and transmigration through vascular endothelia, these findings
provide a mechanism to account for the presence of neutrophils within
meningococcal lesions (29).
Capsulation and LOS structure have been shown to be determinants of
meningococcal survival in human serum, in whole blood, and in the
infant-rat model of meningococcal disease (16, 36-38). We
have been able to show that these bacterial properties can also
influence the degree and pattern of endothelial adhesion molecule
expression. Interestingly, the organisms that induced the highest
levels of adhesion molecules in this study were also those that we have
previously shown to cause the largest reduction in neutrophil CD62L
expression (20). These experiments were performed with whole blood and
appeared to be related to the degree of bacterial killing. In the
present study and in a previous study of meningococcal induction of
endothelial cell tissue factor (10), bacterial killing was
not the explanation for the differing effects of LOS structure and
capsulation on endothelial cell activation. The reasons for the
influence of these bacterial structures on endothelial cell activation
are complex.
Capsulation is an important determinant of B1940 adhesion to HUVEC.
Capsule-deficient mutants are more adherent to endothelial cells than
are the capsulated parent strain and the nonsialylated, capsulated
organism, B1940 cpsD (20). Possession of a
truncated, nonsialylated LOS also influences bacterial adhesion to
HUVEC, as indicated by enhanced binding of the B1940 cps
mutant compared to the B1940 siaD mutant. In this study we
show that adhesion molecule expression is directly correlated with the
adherence of these bacteria to endothelial cells, which indicates that
the adhesive capacity of N. meningitidis is likely to be a
major factor in determining endothelial adhesion molecule expression.
One interpretation of our data is that the more adherent organisms
effectively provide a higher dose of endotoxin to the endothelial cells. This appeared to be the explanation for the enhanced tissue factor expression seen in response to the siaD mutant
compared to the parent strain (10). However, the dose of
endotoxin does not fully account for the differences in adhesion
molecule expression seen in this study. Meningococci, especially the
unencapsulated cps and siaD strains, were more
potent inducers of CD62E expression on HUVEC than were high doses of
endotoxin. Indeed, the level of CD62E caused by these unencapsulated
mutants after only 15 min of exposure was higher than that seen when
HUVEC were continually exposed to endotoxin for a full 5 h. This
was not observed with either ICAM-1 or VCAM-1, where endotoxin was at
least as effective as bacteria at inducing the expression of these two
cell adhesion molecules. Our results show that this differential
activation is true for both purified, smooth E. coli O111:B4
endotoxin and purified group B meningococcal endotoxin, indicating that
this effect is not simply due to structural differences between the endotoxins from the two sources. Why this differential activation should occur is not clear, but it does suggest that the dose of endotoxin may not be the sole determinant of vascular endothelial adhesion molecule expression.
There are a number of bacterial factors that contribute to the
attachment of meningococci to endothelial cells (35). Pili appear to be important for initial endothelial-cell adhesion of encapsulated organisms, while firm attachment may be mediated by the
outer membrane proteins Opa and Opc, particularly in unencapsulated strains (33). These bacterial components that mediate
attachment to and invasion of host cells may also cause activation of
important signal transduction pathways involved in transcriptional
regulation of genes in the inflammatory response. It has been shown
that both pili and Opa from N. gonorrhoeae can activate
epithelial cells via the transcription factors NF-
B and AP-1 to
produce inflammatory cytokines independently of endotoxin
(26). These studies also showed no differences in NF-
B
activation between invading and noninvading strains of N. gonorrhoeae (25). If this were the case, it would
provide a putative mechanism by which the more strongly adherent
organisms were also capable of inducing the highest levels of adhesion
molecule expression. This is presumably because, in unencapsulated
strains, there may be enhanced interaction between opacity proteins and
their ligands. It may also explain the differential patterns of CD62E,
ICAM-1, and VCAM-1 seen in response to the bacteria and purified
endotoxin. It has been demonstrated recently that invasive strains of
N. gonorrhoeae cause greater expression of epithelial ICAM-1
than do noninvasive strains. Interestingly, this was not associated
with an increase in transcription of ICAM-1 mRNA, indicating that
ICAM-1 expression can be modulated by bacteria at the translational or
posttranslational level (13). We suggest that there are
multiple signalling mechanisms that occur when meningococci interact
with vascular endothelial cells. Variations in bacterial structure
could affect these mechanisms. We are currently undertaking studies to
investigate the signal transduction pathways induced in activation of
endothelial cells by the meningococcal mutants.
A further explanation for our results comes from the recent discovery
of human Toll-like receptors that transduce signals in response to
endotoxin in both CD14+ and CD14
cells (43).
There are at least five human homologues of the Toll receptor, and two
of these, TLR2 and TLR4, transduce endotoxin signals (28).
The demonstration of these receptors has highlighted the potential
complexity of endotoxin signalling to host cells. Initial findings
indicate that different Toll receptors may have different properties
and may relate to observed differences in signal transduction
(19). It is becoming clear that the location and form of
endotoxin are central to how it interacts with host endotoxin
recognition molecules (42). This may be critical in how host
cells interact with whole bacteria such as N. meningitidis. Our results demonstrate that LOS structure is an important factor in
determining the pattern of vascular endothelial adhesion molecule expression. The cpsD mutant, which possesses a truncated
LOS, and the lst mutant, which lacks just the terminal
sialic acid of the
-oligosaccharide chain, induced higher levels of
adhesion molecules than did the parent organism. This indicates that
even subtle changes in LOS structure can influence endothelial-cell activation, possibly by influencing the interactions between the bacteria and endothelial-cell endotoxin recognition receptors.
In the light of these findings, we investigated the capacity of
rBPI21, a recombinant form of BPI, a host defense protein with antibacterial and antiendotoxin activities, to modulate the endothelial adhesion molecule response to these different bacterial strains. rBPI21 kills gram-negative bacteria and decreases
tumor necrosis factor alpha production induced by gram-negative
bacteria or LPS in whole blood (41). rBPI21 also
binds to purified endotoxin and abrogates the degree of
endothelial-cell activation (2). In our study, we found that
10 µg of rBPI21 per ml could completely abolish the
induction of cell adhesion molecules on HUVEC when given prior to or
very early following exposure to high doses of purified E. coli endotoxin. However, the pattern seen with organisms was more
complex. Our results show that the effectiveness of rBPI21
in blocking the induction of cell adhesion molecules by bacteria was
dependent not only on the dose of infecting bacteria but also on the
structure of the LOS; in particular, LOS sialylation may influence
rBPI21 activity. Previous studies have shown that BPI and
its N-terminal fragment bind to the lipid A portion of endotoxin,
resulting in endotoxin neutralization (6, 22). How LOS
sialylation could influence rBPI21 binding to the lipid A
component of LPS is not known. Structure of polysaccharide can have an
effect on the inhibitory effects of rBPI21 on some LPSs (3). It has been demonstrated that mutants of E. coli that have incomplete LPS are much more sensitive to
bactericidal permeability-increasing protein than are E. coli strains with intact LPS. It has been proposed that charged
sugar moieties could impede the action of cationic proteins like BPI
(40). Our results indicate that just the presence of sialic
acid on the terminal lacto-N-neotetraose is sufficient to
influence the inhibitory effects of BPI. This is presumably due to the
effect of sialic acid on LOS-BPI interactions. This could be important
in vivo, since most pathogenic meningococci have LOS structures
(immunotypes) that can be sialylated (15). These findings
may also indicate that the dose of rBPI required to inhibit the
inflammatory effects of gram-negative bacteria may have to be optimized
for different bacteria strains.
One of the disappointing features of most anti-inflammatory agents is
that they are effective only when administered prior to or at the same
time as the inflammatory stimulus. Our results indicate that this was
not the case with rBPI21 in vitro. We found that
rBPI21 could influence adhesion molecule expression even when added several hours after the organisms. This was true whether the
organism was adherent or nonadherent. These results are consistent with
previous studies involving E. coli LPS, which have shown that rBPI21 can reverse the LPS-induced expression of CD62E
(E-selectin) after several hours of continuous exposure
(12).
Taken together, these results indicate that LOS structure and the
presence of a capsule can influence the level, kinetics, and profile of
endothelial adhesion molecule expression induced by N. meningitidis. The apparent ability of pathogenic
Neisseria strains to down-regulate their capsule and
desialylate the LOS in natural meningococcal infections would indicate
that the endothelial-cell response to invading organisms may be
variable even for a single strain (8, 9). It would appear
that even limited exposure to some organisms might be able to induce a
rapid influx of inflammatory cells. This may be beneficial in killing
invading organisms but could influence the degree and extent of
endothelial cell injury from activated inflammatory cells
(27). Strategies to combat meningococcal disease should take
into account the multiple signalling pathways that may be activated
during the course of this potentially fatal disease.
 |
ACKNOWLEDGMENTS |
This work was supported by grants from Royal College of
Physicians and Children Nationwide. Karolina Katowicz and Dominic Jack
are funded by The Wellcome Trust.
We thank Mark Peters and the staff of Clinical Microbiology laboratory
at Great Ormond Street Hospital. We thank XOMA for providing us with
the rBPI21 and Russ Dedrick for his valuable comments on
the manuscript.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Immunobiology
Unit, Institute of Child Health, London WC1N 1EH, United Kingdom.
Phone: 44-171-905-2307. Fax: 44-171-813-8494. E-mail:
G.dixon{at}ich.ucl.ac.uk.
Editor:
E. I. Tuomanen
 |
REFERENCES |
| 1.
|
Andersen, S. R.,
K. Bry,
K. Thorseng, and E. Jantzen.
1996.
Heterogeneity of lipopolysaccharides of Neisseria meningitidis revealed by thin-layer chromatography combined with monoclonal antibodies.
J. Microbiol. Methods
25:187.
|
| 2.
|
Arditi, M.,
J. Zhou,
S. H. Huang,
P. M. Luckett,
M. N. Marra, and K. S. Kim.
1994.
Bactericidal/permeability-increasing protein protects vascular endothelial cells from lipopolysaccharide-induced activation and injury.
Infect. Immun.
62:3930-3936[Abstract/Free Full Text].
|
| 3.
|
Capodici, C.,
S. Chen,
Z. Sidorczyk,
P. Elsbach, and J. Weiss.
1994.
Effect of lipopolysaccharide (LPS) chain length on interactions of bactericidal/permeability-increasing protein and its bioactive 23-kilodalton NH2-terminal fragment with isolated LPS and intact Proteus mirabilis and Escherichia coli.
Infect. Immun.
62:259-265[Abstract/Free Full Text].
|
| 4.
|
Carlos, T. M., and J. M. Harlan.
1994.
Leukocyte-endothelial adhesion molecules.
Blood
84:2068-2101[Abstract/Free Full Text].
|
| 5.
|
Dustin, M. L., and T. A. Springer.
1988.
Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells.
J. Cell Biol.
107:321-331[Abstract/Free Full Text].
|
| 6.
|
Gazzano-Santoro, H.,
J. B. Parent,
L. Grinna,
A. Horwitz,
T. Parsons,
G. Theofan,
P. Elsbach,
J. Weiss, and P. J. Conlon.
1992.
High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide.
Infect. Immun.
60:4754-4761[Abstract/Free Full Text].
|
| 7.
|
Hammerschmidt, S.,
C. Birkholz,
U. Zahringer,
B. D. Robertson,
J. van Putten,
O. Ebeling, and M. Frosch.
1994.
Contribution of genes from the capsule gene complex (cps) to lipooligosaccharide biosynthesis and serum resistance in Neisseria meningitidis.
Mol. Microbiol.
11:885-896[Medline].
|
| 8.
|
Hammerschmidt, S.,
R. Hilse,
J. P. van Putten,
R. Gerardy-Schahn,
A. Unkmeir, and M. Frosch.
1996.
Modulation of cell surface sialic acid expression in Neisseria meningitidis via a transposable genetic element.
EMBO J.
15:192-198[Medline].
|
| 9.
|
Hammerschmidt, S.,
A. Muller,
H. Sillmann,
M. Muhlenhoff,
R. Borrow,
A. Fox,
J. van Putten,
W. D. Zollinger,
R. Gerardy-Schahn, and M. Frosch.
1996.
Capsule phase variation in Neisseria meningitidis serogroup B by slipped-strand mispairing in the polysialyltransferase gene (siaD): correlation with bacterial invasion and the outbreak of meningococcal disease.
Mol. Microbiol.
20:1211-1220[Medline].
|
| 10.
|
Heyderman, R. S.,
N. J. Klein,
O. A. Daramola,
S. Hammerschmidt,
M. Frosch,
B. D. Robertson,
M. Levin, and C. A. Ison.
1997.
Induction of human endothelial tissue factor expression by Neisseria meningitidis: the influence of bacterial killing and adherence to the endothelium.
Microb. Pathog.
22:265-276[Medline].
|
| 11.
|
Hill, W. R., and T. D. Kinney.
1947.
The cutaneous lesions in acute meningococcaemia.
JAMA
134:513.
|
| 12.
|
Huang, K.,
D. M. Fishwild,
H. M. Wu, and R. L. Dedrick.
1995.
Lipopolysaccharide-induced E-selectin expression requires continuous presence of LPS and is inhibited by bactericidal/permeability-increasing protein.
Inflammation
19:389-404[Medline].
|
| 13.
|
Jarvis, G. A.,
J. Li, and K. Swanson.
1999.
Invasion of human mucosal epithelial cells by Neisseria gonorrhoeae upregulates expression of intercellular adhesion molecule 1 (ICAM-1).
Infect. Immun.
67:1149-1156[Abstract/Free Full Text].
|
| 14.
|
Jones, D. M.
1995.
Epidemiology of meningococcal disease in Europe and the USA, p. 71-114.
In
K. Cartwright (ed.), Meningococcal disease. John Wiley & Sons Ltd., Chichester, United Kingdom.
|
| 15.
|
Jones, D. M.,
R. Borrow,
A. J. Fox,
S. Gray,
K. A. Cartwright, and J. T. Poolman.
1992.
The lipooligosaccharide immunotype as a virulence determinant in Neisseria meningitidis.
Microb. Pathog.
13:219-224[Medline].
|
| 16.
|
Kahler, C. M.,
L. E. Martin,
G. C. Shih,
M. M. Rahman,
R. W. Carlson, and D. S. Stephens.
1998.
The (alpha2 8)-linked polysialic acid capsule and lipooligosaccharide structure both contribute to the ability of serogroup B Neisseria meningitidis to resist the bactericidal activity of normal human serum.
Infect. Immun.
66:5939-5947[Abstract/Free Full Text].
|
| 17.
|
Karmann, K.,
W. Min,
W. C. Fanslow, and J. S. Pober.
1996.
Activation and homologous desensitization of human endothelial cells by CD40 ligand, tumor necrosis factor, and interleukin 1.
J. Exp. Med.
184:173-182[Abstract/Free Full Text].
|
| 18.
|
Kirsch, E. A.,
R. P. Barton,
L. Kitchen, and B. P. Giroir.
1996.
Pathophysiology, treatment and outcome of meningococcemia: a review and recent experience.
Pediatr. Infect. Dis. J.
15:967-978[Medline].
|
| 19.
|
Kirschning, C. J.,
H. Wesche,
A. T. Merrill, and M. Rothe.
1998.
Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide.
J. Exp. Med.
188:2091-2097[Abstract/Free Full Text].
|
| 20.
|
Klein, N. J.,
C. A. Ison,
M. Peakman,
M. Levin,
S. Hammerschmidt,
M. Frosch, and R. S. Heyderman.
1996.
The influence of capsulation and lipooligosaccharide structure on neutrophil adhesion molecule expression and endothelial injury by Neisseria meningitidis.
J. Infect. Dis.
173:172-179[Medline].
|
| 21.
|
Kotowicz, K.,
R. E. Callard,
K. Friedrich,
D. J. Matthews, and N. Klein.
1996.
Biological activity of IL-4 and IL-13 on human endothelial cells: functional evidence that both cytokines act through the same receptor.
Int. Immunol.
8:1915-1925[Abstract/Free Full Text].
|
| 22.
|
Marra, M. N.,
C. G. Wilde,
J. E. Griffith,
J. L. Snable, and R. W. Scott.
1990.
Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity.
J. Immunol.
144:662-666[Abstract].
|
| 23.
|
Mercier, J. C.,
F. Beaufils,
J. F. Hartmann, and D. Azema.
1988.
Hemodynamic patterns of meningococcal shock in children.
Crit. Care Med.
16:27-33[Medline].
|
| 24.
|
Miles, A. A.,
S. S. Misia, and J. O. Irwin.
1932.
The estimation of the bactericidal power of blood.
Journal Hyg. Camb.
38:732.
|
| 25.
|
Naumann, M.,
T. Rudel,
B. Wieland,
C. Bartsch, and T. F. Meyer.
1998.
Coordinate activation of activator protein 1 and inflammatory cytokines in response to Neisseria gonorrhoeae epithelial cell contact involves stress response kinases.
J. Exp. Med.
188:1277-1286[Abstract/Free Full Text].
|
| 26.
|
Naumann, M.,
S. Wessler,
C. Bartsch,
B. Wieland, and T. F. Meyer.
1997.
Neisseria gonorrhoeae epithelial cell interaction leads to the activation of the transcription factors nuclear factor kappaB and activator protein 1 and the induction of inflammatory cytokines.
J. Exp. Med.
186:247-258[Abstract/Free Full Text].
|
| 27.
|
Richter, J.,
I. Olsson, and T. Andersson.
1990.
Correlation between spontaneous oscillations of cytosolic free Ca2+ and tumor necrosis factor-induced degranulation in adherent human neutrophils.
J. Biol. Chem.
265:14358-14363[Abstract/Free Full Text].
|
| 28.
|
Rock, F. L.,
G. Hardiman,
J. C. Timans,
R. A. Kastelein, and J. F. Bazan.
1998.
A family of human receptors structurally related to Drosophila Toll.
Proc. Natl. Acad. Sci. USA
95:588-593[Abstract/Free Full Text].
|
| 29.
|
Sotto, M. N.,
B. Langer,
S. S. Hoshino, and T. de Brito.
1976.
Pathogenesis of cutaneous lesions in acute meningococcemia in humans: light, immunofluorescent, and electron microscopic studies of skin biopsy specimens.
J. Infect. Dis.
133:506-514[Medline].
|
| 30.
|
Springer, T. A.
1994.
Traffic signals for lymphocyte recirculation and leukocyte migration: the multistep paradigm.
Cell
76:301-314[Medline].
|
| 31.
|
Tsai, C. M.,
C. E. Frasch,
E. Rivera, and H. D. Hochstein.
1989.
Measurement of lipopolysaccharide (endotoxin) in meningococcal protein and polysaccharide preparations for vaccines usage.
J. Biol. Stand.
17:249-258[Medline].
|
| 32.
|
Virji, M.,
H. Kayhty,
D. J. Ferguson,
C. Alexandrescu,
J. E. Heckels, and E. R. Moxon.
1991.
The role of pili in the interactions of pathogenic Neisseria with cultured human endothelial cells.
Mol. Microbiol.
5:1831-1841[Medline].
|
| 33.
|
Virji, M.,
K. Makepeace,
D. J. Ferguson,
M. Achtman, and E. R. Moxon.
1993.
Meningococcal Opa and Opc proteins: their role in colonization and invasion of human epithelial and endothelial cells.
Mol. Microbiol.
10:499-510[Medline].
|
| 34.
|
Virji, M.,
K. Makepeace,
D. J. Ferguson,
M. Achtman,
J. Sarkari, and E. R. Moxon.
1992.
Expression of the Opc protein correlates with invasion of epithelial and endothelial cells by Neisseria meningitidis.
Mol. Microbiol.
6:2785-2795[Medline].
|
| 35.
|
Virji, M.,
K. Makepeace,
I. R. Peak,
D. J. Ferguson,
M. P. Jennings, and E. R. Moxon.
1995.
Opc- and pilus-dependent interactions of meningococci with human endothelial cells: molecular mechanisms and modulation by surface polysaccharides.
Mol. Microbiol.
18:741-754[Medline].
|
| 36.
|
Vogel, U.,
H. Claus,
G. Heinze, and M. Frosch.
1997.
Functional characterization of an isogenic meningococcal alpha-2,3-sialyltransferase mutant: the role of lipooligosaccharide sialylation for serum resistance in serogroup B meningococci.
Med. Microbiol. Immunol. Berlin
186:159-166[Medline].
|
| 37.
|
Vogel, U.,
H. Claus,
G. Heinze, and M. Frosch.
1999.
Role of lipopolysaccharide sialylation in serum resistance of serogroup B and C meningococcal disease isolates.
Infect. Immun.
67:954-957[Abstract/Free Full Text].
|
| 38.
|
Vogel, U.,
S. Hammerschmidt, and M. Frosch.
1996.
Sialic acids of both the capsule and the sialylated lipooligosaccharide of Neisseria meningitidis serogroup B are prerequisites for virulence of meningococci in the infant rat.
Med. Microbiol. Immunol. Berlin
185:81-87[Medline].
|
| 39.
|
von Asmuth, E. J.,
M. A. Dentener,
V. Bazil,
M. G. Bouma,
J. F. Leeuwenberg, and W. A. Buurman.
1993.
Anti-CD14 antibodies reduce responses of cultured human endothelial cells to endotoxin.
Immunology
80:78-83[Medline].
|
| 40.
|
Weiss, J.,
Q. S. Beckerdite, and P. Elsbach.
1980.
Resistance of gram-negative bacteria to purified bactericidal leukocyte proteins: relation to binding and bacterial lipopolysaccharide structure.
J. Clin. Investig.
65:619-628.
|
| 41.
|
Weiss, J.,
P. Elsbach,
C. Shu,
J. Castillo,
L. Grinna,
A. Horwitz, and G. Theofan.
1992.
Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.
J. Clin. Investig.
90:1122-1130.
|
| 42.
|
Wright, S. D.
1999.
Toll, a new piece in the puzzle of innate immunity.
J. Exp. Med.
189:605-609[Free Full Text].
|
| 43.
|
Yang, R. B.,
M. R. Mark,
A. Gray,
A. Huang,
M. H. Xie,
M. Zhang,
A. Goddard,
W. I. Wood,
A. L. Gurney, and P. J. Godowski.
1998.
Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling.
Nature
395:284-288[Medline].
|
Infection and Immunity, November 1999, p. 5626-5633, Vol. 67, No. 11
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Schubert-Unkmeir, A., Sokolova, O., Panzner, U., Eigenthaler, M., Frosch, M.
(2007). Gene Expression Pattern in Human Brain Endothelial Cells in Response to Neisseria meningitidis. Infect. Immun.
75: 899-914
[Abstract]
[Full Text]
-
Pridmore, A. C., Jarvis, G. A., John, C. M., Jack, D. L., Dower, S. K., Read, R. C.
(2003). Activation of Toll-Like Receptor 2 (TLR2) and TLR4/MD2 by Neisseria Is Independent of Capsule and Lipooligosaccharide (LOS) Sialylation but Varies Widely among LOS from Different Strains. Infect. Immun.
71: 3901-3908
[Abstract]
[Full Text]
-
Harrison, O. B., Robertson, B. D., Faust, S. N., Jepson, M. A., Goldin, R. D., Levin, M., Heyderman, R. S.
(2002). Analysis of Pathogen-Host Cell Interactions in Purpura Fulminans: Expression of Capsule, Type IV Pili, and PorA by Neisseria meningitidis In Vivo. Infect. Immun.
70: 5193-5201
[Abstract]
[Full Text]
-
Faust, S. N., Levin, M., Harrison, O. B., Goldin, R. D., Lockhart, M. S., Kondaveeti, S., Laszik, Z., Esmon, C. T., Heyderman, R. S.
(2001). Dysfunction of Endothelial Protein C Activation in Severe Meningococcal Sepsis. NEJM
345: 408-416
[Abstract]
[Full Text]
-
Dixon, G. L. J., Newton, P. J., Chain, B. M., Katz, D., Andersen, S. R., Wong, S., van der Ley, P., Klein, N., Callard, R. E.
(2001). Dendritic Cell Activation and Cytokine Production Induced by Group B Neisseria meningitidis: Interleukin-12 Production Depends on Lipopolysaccharide Expression in Intact Bacteria. Infect. Immun.
69: 4351-4357
[Abstract]
[Full Text]
-
Wells, D. B., Tighe, P. J., Wooldridge, K. G., Robinson, K., Ala' Aldeen, D. A. A.
(2001). Differential Gene Expression during Meningeal-Meningococcal Interaction: Evidence for Self-Defense and Early Release of Cytokines and Chemokines. Infect. Immun.
69: 2718-2722
[Abstract]
[Full Text]